Q-omics provides the consensus-scored RBPJP2 profile across patient tissues and cancer cell-line models. RBPJP2 expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in KIRC. Additionally, RBPJP2 RNA expression shows 3,100 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight KIRC, and STAD as cancer lineages where RBPJP2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.